Catalyst Wire Dossier Catalyst Wire Dossier

Lipfendra

enlicitide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lipfendra. Get the full timeline:

Most recent: FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol

See pricing